Your search returned 14 results.

Sort
Results
1.
Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 35065842
Year: 2022
Citation:
  • European Journal of Surgical Oncology. 48(5):946-955, 2022 05.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chang D, Sugarbaker PH
2.
Revised prognostic indicators for treatment of lymph node positive colorectal peritoneal metastases. MedStar authors:
  • Chang, David
  • Sugarbaker, Paul H
PMID:
  • 35032331
Year: 2022
Citation:
  • Journal of Surgical Oncology. 125(5):889-900, 2022 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Chang D, Sugarbaker PH
3.
After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 35398760
Year: 2022
Citation:
  • Surgical Oncology. 42:101757, 2022 Jun.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
4.
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts. MedStar authors:
  • Sugarbaker, Paul
PMID:
  • 32912822
Year: 2020
Citation:
  • Clinical Colorectal Cancer. 19(4):277-284, 2020 12.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Beate R, Brandon M, Claudio Q, David M, Diane G, Ignace H, Janina E, Lana B, Markus G, Martin PP, Olivier G, Paul S, Pompiliu P, Steffen T, Yan L, Yutaka Y
5.
The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 30075978
Year: 2018
Citation:
  • European Journal of Surgical Oncology. 44(12):1942-1948, 2018 12.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bushati M, Cashin PH, Ceelen W, de Hingh IHJT, Deraco M, Dube P, Glehen O, Gonzalez-Moreno S, Lehmann K, Li Y, Moran B, Morris DL, Piso P, Quadros CA, Rovers KP, Somashekhar SP, Sommariva A, Spiliotis J, Sugarbaker PH, Teo MCC, Verwaal VJ, Yonemura Y
6.
Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 29428475
Year: 2018
Citation:
  • European Journal of Surgical Oncology. 44(6):805-809, 2018 06.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
7.
Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 25071322
Year: 2014
Citation:
  • World Journal of Gastroenterology. 20(28):9286-91, 2014 Jul 28.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
8.
Port site metastases after minimally invasive resection for colorectal cancer: A retrospective study of 13 patients. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 31196489
Year: 2019
Citation:
  • Surgical Oncology. 29:20-24, 2019 Jun.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bello BL, Kwong MLM, Sampah MES, Sugarbaker PH
9.
Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. MedStar authors:
  • Ihemelandu, Chukwuemeka
  • Paul, Bikram K
  • Sugarbaker, Paul H
PMID:
  • 29420428
Year: 2018
Citation:
  • Diseases of the Colon & Rectum. 61(3):347-354, 2018 Mar
Institution:
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ihemelandu C, Paul BK, Sugarbaker PH
10.
Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 25897165
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(18):2122-3, 2015 Jun 20.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Letter
Form of publication:
  • Journal Article
All authors:
  • O'Dwyer S, Sugarbaker PH, Verwaal VJ
11.
Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 35177314
Year: 2022
Citation:
  • European Journal of Surgical Oncology. 48(7):1619-1625, 2022 07.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Chang D, Sugarbaker PH
12.
The hepatic bridge. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 29699839
Year: 2018
Citation:
  • European Journal of Surgical Oncology. 44(7):1083-1086, 2018 07.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
13.
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 22846841
Year: 2012
Citation:
  • Lancet Oncology. 13(8):e362-9, 2012 Aug.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ryan DP, Sugarbaker PH
14.
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33004272
Year: 2021
Citation:
  • European Journal of Surgical Oncology. 47(4):738-742, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Evans S, Nagourney AJ, Nagourney RA, Sugarbaker PH, Tran PH
Pages

Powered by Koha